PA
LX

PharVision Advisers’s LexinFintech Holdings LX Stock Holding History

PharVision Advisers’s Portfolio LX Stock Details LX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104,360
Closed -$341K – 413
2025
Q4 		$341K Sell
104,360
-9,568
-8% -$39.3K 0.17% 206
2025
Q3 		$607K Buy
+113,928
New +$728K 0.34% 10

Other funds holding LX

BAM
Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's LX Position: Q1 2026 in Review

PharVision Advisers sold out of LexinFintech Holdings (LX) in Q1 2026, closing a stake of 104,360 shares — an estimated $341K sold.

PharVision Advisers first reported a position in LX in Q3 2025 and held it in 2 quarters. The position peaked at $607K in Q3 2025. 95 funds tracked by Wall St. Rank hold LX as of Q1 2026.

  • PharVision Advisers reported no remaining LexinFintech Holdings position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 104,360 LexinFintech Holdings shares in Q1 2026, an estimated $341K.
  • PharVision Advisers first reported a position in LexinFintech Holdings in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's LexinFintech Holdings position peaked at $607K in Q3 2025.
  • 95 funds tracked by Wall St. Rank held LexinFintech Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.